A mitochondrial strategy for safeguarding the reprogrammed genome

Cell Regeneration

Volumn 3, Issue 1, 2014, Pages 3:5-

  Prigione, Alessandro ^a   Adjaye, James ^b,c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antioxidants; Genomic aberrations; iPSCs; Mitochondria; Reprogramming

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; CELL NUCLEUS DNA; KRUPPEL LIKE FACTOR 4; MITOCHONDRIAL DNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; CELL HYPOXIA; CELL PROLIFERATION; CELL PROTECTION; CELL RESPIRATION; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; GLYCOLYSIS; HUMAN; MITOCHONDRION; NOTE; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TRANSGENE;

EID: 84988239965     PISSN: None     EISSN: 20459769     Source Type: Journal    
DOI: 10.1186/2045-9769-3-5     Document Type: Note

References (21)

1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84. 10.1016/j.biocel.2006.07.001, 16978905.
2. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247. 10.1038/35041687, 11089981.
3. Ji J, Sharma V, Qi S, Guarch ME, Zhao P, Luo Z, Fan W, Wang Y, Mbabaali F, Neculai D, Esteban MA, McPherson JD, Batada NN. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells. Stem Cell Reports 2014, 2(1):44-51. 10.1016/j.stemcr.2013.11.004, 3916753, 24511469.
4. Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6(1):71-79. 10.1016/j.stem.2009.12.001, 20036631.
5. Mah N, Wang Y, Liao MC, Prigione A, Jozefczuk J, Lichtner B, Wolfrum K, Haltmeier M, Flottmann M, Schaefer M, Hahn A, Mrowka R, Klipp E, Andrade-Navarro MA, Adjaye J. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network. PLoS One 2011, 6(8):e24351. 10.1371/journal.pone.0024351, 3164204, 21909390.
6. Wang T, Chen K, Zeng X, Yang J, Wu Y, Shi X, Qin B, Zeng L, Esteban MA, Pan G, Pei D. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011, 9(6):575-587. 10.1016/j.stem.2011.10.005, 22100412.
7. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465(7295):175-181. 10.1038/nature09017, 20418860.
8. Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28(4):721-733. 10.1002/stem.404, 20201066.
9. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011, 14(2):264-271. 10.1016/j.cmet.2011.06.011, 3156138, 21803296.
10. Gruning NM, Ralser M. Cancer: sacrifice for survival. Nature 2011, 480(7376):190-191. 10.1038/480190a, 22158241.
11. Prigione A, Lichtner B, Kuhl H, Struys EA, Wamelink M, Lehrach H, Ralser M, Timmermann B, Adjaye J. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells 2011, 29(9):1338-1348.
12. Prigione A, Rohwer N, Hoffmann S, Mlody B, Drews K, Bukowiecki R, Blumlein K, Wanker EE, Ralser M, Cramer T, Adjaye J. HIF1alpha modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2. Stem Cells 2014, 32(2):364-376. 10.1002/stem.1552, 24123565.
13. Yanes O, Clark J, Wong DM, Patti GJ, Sanchez-Ruiz A, Benton HP, Trauger SA, Desponts C, Ding S, Siuzdak G. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 2010, 6(6):411-417. 10.1038/nchembio.364, 2873061, 20436487.
14. Armstrong L, Tilgner K, Saretzki G, Atkinson SP, Stojkovic M, Moreno R, Przyborski S, Lako M. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28(4):661-673. 10.1002/stem.307, 20073085.
15. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5(3):237-241. 10.1016/j.stem.2009.08.001, 19716359.
16. Young MA, Larson DE, Sun CW, George DR, Ding L, Miller CA, Lin L, Pawlik KM, Chen K, Fan X, Schmidt H, Kalicki-Veizer J, Cook LL, Swift GW, Demeter RT, Wendl MC, Sands MS, Mardis ER, Wilson RK, Townes TM, Ley TJ. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 2012, 10(5):570-582. 10.1016/j.stem.2012.03.002, 3348423, 22542160.
17. Cheng L, Hansen NF, Zhao L, Du Y, Zou C, Donovan FX, Chou BK, Zhou G, Li S, Dowey SN, Ye Z, Chandrasekharappa SC, Yang H, Mullikin JC, Liu PP. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 2012, 10(3):337-344. 10.1016/j.stem.2012.01.005, 3298448, 22385660.
18. Miller DM, Thomas SD, Islam A, Muench D, Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res 2012, 18(20):5546-5553. 10.1158/1078-0432.CCR-12-0977, 3505847, 23071356.
19. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471(7336):63-67. 10.1038/nature09805, 3074107, 21368825.
20. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res 2013, 6(1):10-21. 10.1007/s12265-012-9431-2, 3750736, 23247633.
21. Pera MF. Stem cells: The dark side of induced pluripotency. Nature 2011, 471(7336):46-47. 10.1038/471046a, 21368819.